Protagenic Therapeutics- Warrants (13/04/2025) Long Term Debt

As of the most recent data (December 2025), PTIXW shows a long-term debt of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PTIXW's long-term debt is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Protagenic Therapeutics- Warrants (13/04/2025) is outperforming or lagging.

Tracking PTIXW's long-term debt over time shows whether Protagenic Therapeutics- Warrants (13/04/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Protagenic Therapeutics- Warrants (13/04/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $0) with ownership activity and broader fundamentals.

Protagenic Therapeutics- Warrants (13/04/2025)'s long-term debt is $0; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.